Stay updated on PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Sign up to get notified when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.

Latest updates to the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision log updated to add v3.5.0 and remove v3.4.3.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.3 is now shown, replacing the previous v3.4.2.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check49 days agoChange DetectedA new Revision: v3.4.2 is shown, and the prior Revision: v3.4.1 notice is removed. The changes appear to be site-wide UI/notice updates rather than updates to the study details.SummaryDifference0.3%

- Check56 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check63 days agoChange DetectedGlossary visibility was added to the study page. Wording and capitalization for QC criteria and FEAR Act data were standardized, and the revision updated to v3.4.0.SummaryDifference0.2%

- Check77 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3 label; this is a minor technical update with no impact on trial content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PDR001/MBG453 w/ Decitabine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PDR001/MBG453 w/ Decitabine in AML Clinical Trial page.